- Home
- -
Management
Prof. Sam Muchina Kinyanjui
Director - IDeAL & Head Of Training
Current Work
Since 2008, Dr Samson Kinyanjui has overseen rapid growth in support for young African scientists. His vision extends further, though, as he hopes to help establish research networks to encourage scientists across Africa and build the continent’s future research capacity.Collaborations
No active details yet
Biography
Sam started his research career in 1994 at the Wellcome Trust Labs in Nairobi doing malaria pharmacology studies and subsequently moved to Kilifi to study immunity to malaria as part of his PhD. In 2004, Sam was awarded a Wellcome Trust training fellowship. During the fellowship Sam also developed interest for capacity building for research and eventually in 2008 took up a post as the Head of Training and Capacity Building at the Programme. Sam’s roles include administering training activities and developing strategies for capacity building at the Programme and within the East African region as head of training at the KEMRI-Wellcome Trust Research Programme in Kenya.
Current Work
Since 2008, Dr Samson Kinyanjui has overseen rapid growth in support for young African scientists. His vision extends further, though, as he hopes to help establish research networks to encourage scientists across Africa and build the continent’s future research capacity.Collaborations
No active details yet
Project Research
No active details yet
Publications
Designing and delivering bioinformatics project-based learning in East Africa.
Kibet, C. K., Entfellner, J. D., Jjingo, D., de Villiers, E. P., de Villiers, S., Wambui, K., Kinyanjui, S., Masiga, D.
BMC Bioinformatics, (2024). 25:150
Antibody-Dependent Respiratory Burst against Plasmodium falciparum Merozoites in Individuals Living in an Area with Declining Malaria Transmission.
Mutemi, D. D., Tuju, J., Ogwang, R., Nyamako, L., Wambui, K. M., Cruz, I. R., Villner, P., Yman, V., Kinyanjui, S. M., Rooth, I., Ngasala, B., Färnert, A., Osier, F. H. A.
Vaccines (Basel), (2024). 12:
Antibody-Dependent Respiratory Burst against Plasmodium falciparum Merozoites in Individuals Living in an Area with Declining Malaria Transmission.
Mutemi, D. D., Tuju, J., Ogwang, R., Nyamako, L., Wambui, K. M., Cruz, I. R., Villner, P., Yman, V., Kinyanjui, S. M., Rooth, I., Ngasala, B., Färnert, A., Osier, F. H. A.
Vaccines (Basel), (2024). 12:
Anti-merozoite antibodies induce natural killer cell effector function and are associated with immunity against malaria.
Odera, D. O., Tuju, J., Mwai, K., Nkumama, I. N., Fürle, K., Chege, T., Kimathi, R., Diehl, S., Musasia, F. K., Rosenkranz, M., Njuguna, P., Hamaluba, M., Kapulu, M. C., Frank, R., Osier, F. H. A., Abdi, A. I., Chi, P. C., de Laurent, Z., Jao, I., Kamuya, D., Kamuyu, G., Makale, J., Murungi, L., Musyoki, J., Muthui, M., Mwacharo, J., Kariuki, S., Mwanga, D., Mwongeli, J., Ndungu, F., Njue, M., Nyangweso, G., Kimani, D., Ngoi, J. M., Musembi, J., Ngoto, O., Otieno, E., Ooko, M., Shangala, J., Wambua, J., Mohammed, K. S., Omuoyo, D., Mosobo, M., Kibinge, N., Kinyanjui, S., Bejon, P., Lowe, B., Marsh, K., Marsh, V., Abebe, Y., Billingsley, P. F., Sim, B. K. L., Hoffman, S. L., James, E. R., Richie, T. L., Audi, A., Olewe, F., Oloo, J., Ongecha, J., Ongas, M. O., Koskei, N., Bull, P. C., Hodgson, S. H., Kivisi, C., Imwong, M., Murphy, S. C., Ogutu, B., Tarning, J., Winterberg, M., Williams, T. N.
Sci Transl Med, (2023). 15:eabn5993
How to improve research capacity strengthening efforts: learning from the monitoring and evaluation of four research consortia in Africa.
Kasprowicz, V. O., Jeffery, C., Mbuvi, D., Bukirwa, V., Ouattara, K., Kirimi, F., Heitz-Tokpa, K., Gorrethy, M., Chopera, D., Nakanjako, D., Bonfoh, B., Elliott, A., Kinyanjui, S., Bates, I., Ndung'u, T.
Health Res Policy Syst, (2023). 21:109
Malaria attributable fractions with changing transmission intensity: Bayesian latent class vs logistic models.
Mwai, K., Nkumama, I., Thairu, A., Mburu, J., Odera, D., Kimathi, R., Nyamako, L., Tuju, J., Kinyanjui, S., Musenge, E., Osier, F.
Malar J, (2022). 21:326
Determinants of utilization of malaria preventive measures during pregnancy among women aged 15 to 49 years in Kenya: an analysis of the Malaria Indicator Survey 2020.
Mkubwa, B., Kagura, J., Chirwa, T., Ibisomi, L., Kinyanjui, S.
Malar J, (2022). 21:398
A framework for managing health research capacity strengthening consortia: addressing tensions and enhancing capacity outcomes.
Tagoe, N., Pulford, J., Kinyanjui, S., Molyneux, S.
BMJ Glob Health, (2022). 7:e009472
Breadth of Antibodies to Plasmodium falciparum Variant Surface Antigens Is Associated With Immunity in a Controlled Human Malaria Infection Study.
Kimingi, H. W., Kinyua, A. W., Achieng, N. A., Wambui, K. M., Mwangi, S., Nguti, R., Kivisi, C. A., Jensen, A. T. R., Bejon, P., Kapulu, M. C., Abdi, A. I., Kinyanjui, S. M., CHMI-SIKA Study Team
Front Immunol, (2022). 13:894770
Increasing diversity in genomics requires investment in equitable partnerships and capacity building.
Martin, A. R., Stroud, R. E., Abebe, T., Akena, D., Alemayehu, M., Atwoli, L., Chapman, S. B., Flowers, K., Gelaye, B., Gichuru, S., Kariuki, S. M., Kinyanjui, S., Korte, K. J., Koen, N., Koenen, K. C., Newton, C. R. J. C., Olivares, A. M., Pollock, S., Post, K., Singh, I., Stein, D. J., Teferra, S., Zingela, Z., Chibnik, L. B.
Nat Genet, (2022). 54:740-745